Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
<strong>Background<br></strong> Low-dose corticosteroids have been shown to reduce mortality for patients with COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation). We evaluat...
Main Authors: | Horby, PW, Emberson, JR, Basnyat, B, Campbell, M, Peto, L, Pessoa-Amorim, G, Staplin, N, Hamers, RL, Mafham, M, Haynes, R, Landray, M |
---|---|
Other Authors: | RECOVERY Collaborative Group |
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2023
|
Similar Items
-
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Mafham, M, et al.
Published: (2021) -
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Landray, M, et al.
Published: (2022) -
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Horby, P, et al.
Published: (2024) -
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Horby, P, et al.
Published: (2021) -
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
by: RECOVERY Collaborative Group, et al.
Published: (2022)